Propiedad y actividad de insiders de PharmaCyte Biotech, Inc. (PMCB): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $0.42 |
| Capitalización | $4M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-03-31 | WALKER WAYNE REMELL | J-Other | ||
| 2026-03-31 | Abecassis Michael M | J-Other | ||
| 2026-03-31 | SCHECHTER JONATHAN | J-Other | ||
| 2026-03-31 | WEINSTEIN ROBERT | J-Other | ||
| 2026-03-31 | WEINSTEIN ROBERT | A-Award | 119,170 | $80K |
| 2026-03-31 | WALKER WAYNE REMELL | A-Award | 119,170 | $80K |
| 2026-03-31 | SCHECHTER JONATHAN | A-Award | 119,170 | $80K |
| 2026-03-31 | Abecassis Michael M | A-Award | 119,170 | $80K |
| 2026-01-07 | Silverman Joshua | P-Purchase | 40,000 | $33K |
| 2026-01-06 | Silverman Joshua | P-Purchase | 30,000 | $24K |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $3.5M | $1.1M | $515253 | $894861 | $2.2M | $85.4M | $68.0M | $50.2M | $15.2M | $18.6M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $366316 | $18.5M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $3.7M | $240766 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $3.5M | $1.3M | $653404 | $1.0M | $2.3M | $85.5M | $68.1M | $50.4M | $22.4M | $37.4M |
| Inmovilizado Material | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $1.5M | $1.5M | 0 |
| Activos Totales | $8.7M | $6.4M | $5.8M | $6.2M | $7.4M | $90.6M | $73.3M | $59.9M | $55.2M | $46.8M |
| Cuentas por Pagar | $365600 | $352621 | $121885 | $185842 | $172261 | $205361 | $128281 | $389369 | $399204 | $271102 |
| Deuda a Corto | 0 | 0 | 0 | $28918 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $580248 | $644168 | $742851 | $1.0M | $724778 | $704370 | $586581 | $7.4M | $2.9M | $826424 |
| Deuda a Largo | 0 | 0 | 0 | $46282 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $580248 | $644168 | $742851 | $1.1M | $724778 | $704370 | $586581 | $20.4M | $3.3M | $11.8M |
| Reservas | -$89.1M | -$96.0M | -$100.0M | -$103.9M | -$107.4M | -$111.6M | -$116.0M | -$115.6M | -$85.0M | -$104.4M |
| Patrimonio Neto | $8.1M | $5.8M | $5.0M | $5.1M | $6.7M | $89.9M | $72.7M | $39.5M | $51.9M | $33.3M |
| Deuda Total | 0 | 0 | 0 | $75200 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deuda Neta | -$3.5M | -$1.1M | -$515253 | -$819661 | -$2.2M | -$85.4M | -$68.0M | -$50.2M | -$15.5M | -$37.1M |
| Capital Circulante | $3.0M | $639697 | -$89447 | $6248 | $1.6M | $84.8M | $67.6M | $43.0M | $19.5M | $36.6M |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 45.28 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -2.67 |
Rentabilidad
| Rentabilidad sobre capital | -50.84% |
| Rentabilidad sobre capital invertido | -14.92% |
| Rentabilidad sobre activos | -41.55% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: BCLI · CYCN · IBO · KTTA · NBY · PLRZ · QNRX
Explorar sector: Healthcare · Biotechnology
Más secciones de PMCB: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones